Drugs & TargetsFree Abecma receives positive CHMP opinion for relapsed and refractory multiple myeloma June 25, 2021Vol.47 No.25
Drugs & TargetsFree Opdivo receives positive CHMP opinion as adjuvant treatment for GEJ cancer patients with residual pathologic disease following chemoradiotherapy June 25, 2021Vol.47 No.25
Drugs & TargetsFree European Commission approves Onureg for certain AML subtypes June 25, 2021Vol.47 No.25
FreeIn the Archives On the shoulders of giants: Research milestones and the Rabson-Kirschstein photo archive June 18, 2021Vol.47 No.24
EditorialFree The Cancer Letter receives 8 journalism, design awards June 18, 2021Vol.47 No.24By Paul Goldberg
Free Narjust Duma: “To all minority fellows, residents, and medical students—you belong in medicine” June 11, 2021Vol.47 No.23By Alexandria Carolan
FreeIn the Archives Roswell Park, MD Anderson, Memorial Sloan Kettering: The cancer centers that set the model for a nation June 11, 2021Vol.47 No.23
Cancer History ProjectFree Dan Hayes witnessed cancer history, now he is documenting it in a podcast June 04, 2021Vol.47 No.22By Alexandria Carolan
Free As Axel Grothey becomes an emblem of sexual misconduct in medicine, many warn that the problem is bigger than one man June 04, 2021Vol.47 No.22By Alexandria Carolan and Paul Goldberg
FreeWhite House Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H June 04, 2021Vol.47 No.22By Matthew Bin Han Ong
